Bernales, Maylin B.

HRN: 21-65-97  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/02/2022
CEFUROXIME 500MG (TAB)
08/02/2022
08/09/2022
ORAL
500mg
BID
SP CS; PROM; TMSAF
Waiting Final Action 

Indication:  ProphylaxisEmpiric    Type of Infection:  Intra-abdominalReproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: